Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Promethazine | hsa00030 | Pentose phosphate pathway | 3.06E-04 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | | Promethazine | hsa00040 | Pentose and glucuronate interconversions | 1.95E-03 | 2 | P15121, O60701 | AKR1B1, UGDH | More | | Promethazine | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Promethazine | hsa00053 | Ascorbate and aldarate metabolism | 3.63E-04 | 3 | P51648, P14550, Q9UEF7 | ALDH3A2, AKR1A1, KL | More | | Promethazine | hsa00061 | Fatty acid biosynthesis | 4.83E-02 | 1 | P33121 | ACSL1 | More | | Promethazine | hsa00071 | Fatty acid degradation | 4.66E-02 | 3 | O75521, P11766, P33121 | ECI2, ADH5, ACSL1 | More | | Promethazine | hsa00190 | Oxidative phosphorylation | 6.99E-05 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Promethazine | hsa00220 | Arginine biosynthesis | 2.86E-02 | 2 | P15104, P05089 | GLUL, ARG1 | More | | Promethazine | hsa00230 | Purine metabolism | 4.60E-02 | 4 | Q13370, P36959, Q13956, P27707 | PDE3B, GMPR, PDE6H, DCK | More | | Promethazine | hsa00240 | Pyrimidine metabolism | 2.34E-04 | 4 | P21589, P32320, P27707, P04183 | NT5E, CDA, DCK, TK1 | More | | Promethazine | hsa00280 | Valine, leucine and isoleucine degradation | 4.55E-02 | 2 | P21953, P51648 | BCKDHB, ALDH3A2 | More | | Promethazine | hsa00310 | Lysine degradation | 7.78E-05 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | | Promethazine | hsa00440 | Phosphonate and phosphinate metabolism | 3.98E-02 | 1 | Q9Y6K0 | CEPT1 | More | | Promethazine | hsa00500 | Starch and sucrose metabolism | 5.45E-05 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Promethazine | hsa00513 | Various types of N-glycan biosynthesis | 4.96E-02 | 1 | Q9NR34 | MAN1C1 | More | | Promethazine | hsa00515 | Mannose type O-glycan biosynthesis | 2.43E-03 | 1 | O75072 | FCMD | More | | Promethazine | hsa00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 4.77E-02 | 1 | Q7LGA3 | HS2ST1 | More | | Promethazine | hsa00564 | Glycerophospholipid metabolism | 4.63E-03 | 4 | P48651, Q6P1A2, Q9Y6K0, P23743 | PTDSS1, MBOAT5, CEPT1, DGKA | More | | Promethazine | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Promethazine | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Promethazine | hsa00591 | Linoleic acid metabolism | 8.36E-04 | 1 | P11712 | CYP2C9 | More | | Promethazine | hsa00600 | Sphingolipid metabolism | 3.01E-02 | 2 | Q9BX95, P06280 | SGPP1, GLA | More | | Promethazine | hsa00620 | Pyruvate metabolism | 8.80E-06 | 6 | P40925, P40926, P07195, P51648, P14550, P11766 | MDH1, MDH2, LDHB, ALDH3A2, AKR1A1, ADH5 | More | | Promethazine | hsa00630 | Glyoxylate and dicarboxylate metabolism | 5.60E-06 | 2 | P40925, P15104 | MDH1, GLUL | More | | Promethazine | hsa00670 | One carbon pool by folate | 3.99E-02 | 2 | O95954, Q99707 | FTCD, MTR | More | | Promethazine | hsa00730 | Thiamine metabolism | 7.19E-04 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Promethazine | hsa00740 | Riboflavin metabolism | 2.15E-03 | 2 | Q969G6, P24666 | RFK, ACP1 | More | | Promethazine | hsa00770 | Pantothenate and CoA biosynthesis | 2.26E-04 | 3 | O95498, O95497, Q9NRN7 | VNN2, VNN1, AASDHPPT | More | | Promethazine | hsa00790 | Folate biosynthesis | 2.76E-03 | 3 | P07101, P15121, P42330 | TH, AKR1B1, AKR1C3 | More | | Promethazine | hsa00920 | Sulfur metabolism | 3.01E-02 | 1 | O95571 | ETHE1 | More | | Promethazine | hsa00970 | Aminoacyl-tRNA biosynthesis | 1.67E-07 | 4 | O95363, P54136, P14868, Q15046 | FARS2, RARS1, DARS, KARS | More | | Promethazine | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 6.38E-04 | 3 | P78417, P09211, P11712 | GSTO1, GSTP1, CYP2C9 | More | | Promethazine | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Promethazine | hsa00983 | Drug metabolism - other enzymes | 7.78E-04 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | | Promethazine | hsa01100 | Metabolic pathways | 6.77E-03 | 32 | Q9Y234, P15144, Q99707, P29218, P11310, P27707, P32320, Q13370, P36959, Q13956, P06280, P30043, P24666, Q02252, O60701, O14772, O95954, P33121, Q02318, P42330, P04406, Q13093, Q9NY28, O15466, Q9BX95, P09960, Q9P2R7, Q9UHY7, P35573, Q13488, Q16718, Q02809 | LIPT1, ANPEP, MTR, IMPA1, ACADM, DCK, CDA, PDE3B, GMPR, PDE6H, GLA, BLVRB, ACP1, ALDH6A1, UGDH, FPGT, FTCD, ACSL1, CYP27A1, AKR1C3, GAPDH, PLA2G7, GALNT8, ST8SIA5, SGPP1, LTA4H, SUCLA2, ENOPH1, AGL, TCIRG1, NDUFA5, PLOD1 | More | | Promethazine | hsa01200 | Carbon metabolism | 4.32E-02 | 3 | P51854, P37837, P60891 | TKTL1, TALDO1, PRPS1 | More | | Promethazine | hsa01230 | Biosynthesis of amino acids | 2.60E-02 | 3 | P51854, P60891, P37837 | TKTL1, PRPS1, TALDO1 | More | | Promethazine | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 1.82E-02 | 1 | P04049 | RAF1 | More | | Promethazine | hsa01522 | Endocrine resistance | 2.16E-02 | 1 | P04049 | RAF1 | More | | Promethazine | hsa01524 | Platinum drug resistance | 4.45E-02 | 4 | P10415, Q13489, P78417, P43246 | BCL2, BIRC3, GSTO1, MSH2 | More | | Promethazine | hsa02010 | ABC transporters | 1.99E-04 | 4 | P45844, P08183, Q8IZY2, Q99758 | ABCG1, ABCB1, ABCA7, ABCA3 | More | | Promethazine | hsa03008 | Ribosome biogenesis in eukaryotes | 4.42E-02 | 3 | Q9NYH9, P78345, Q9BVP2 | UTP6, RPP38, GNL3 | More | | Promethazine | hsa03010 | Ribosome | 3.40E-09 | 18 | P62753, P42677, P25398, P32969, P40429, P62917, P62829, P46776, Q9H0U6, Q07020, P62910, P18077, Q02878, P36578, P27635, P05386, P62249, P23396 | RPS6, RPS27, RPS12, RPL9, RPL13A, RPL8, RPL23, RPL27A, MRPL18, RPL18, RPL32, RPL35A, RPL6, RPL4, RPL10, RPLP1, RPS16, RPS3 | More | | Promethazine | hsa03013 | RNA transport | 1.14E-05 | 15 | P62826, O14980, P52298, Q09161, O14893, P61326, Q7Z3B4, P35658, P63279, Q14152, O75822, P78345, Q14240, Q9Y6A5, P51114 | RAN, XPO1, NCBP2, NCBP1, GEMIN2, MAGOH, NUP54, NUP214, UBE2I, EIF3A, EIF3J, RPP38, EIF4A2, TACC3, FXR1 | More | | Promethazine | hsa03015 | mRNA surveillance pathway | 3.62E-02 | 3 | O43148, P61326, P52298 | RNMT, MAGOH, NCBP2 | More | | Promethazine | hsa03020 | RNA polymerase | 7.65E-07 | 5 | P30876, P24928, P62487, Q9GZM3, P52435 | POLR2B, POLR2A, POLR2G, POLR2J2, POLR2J | More | | Promethazine | hsa03022 | Basal transcription factors | 3.32E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | | Promethazine | hsa03040 | Spliceosome | 2.30E-11 | 19 | Q14562, O43143, O60508, P17844, O14776, P08579, P26368, O75940, P52298, P09651, Q15365, O75494, Q07955, Q01130, Q13243, P11142, O95777, O43447, P61326 | DHX8, DHX15, CDC40, DDX5, TCERG1, SNRPB2, U2AF2, SMNDC1, NCBP2, HNRNPA1, PCBP1, FUSIP1, SFRS1, SFRS2, SFRS5, HSPA8, LSM8, PPIH, MAGOH | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P0DP23 | CALM1 | Calmodulin-1 | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.942 | P0DP25 | CALM3 | Calmodulin-3 | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.942 | P0DP24 | CALM2 | Calmodulin-2 | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.942 | P0DP23 | CALM1 | Calmodulin-1 | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.963 | P0DP25 | CALM3 | Calmodulin-3 | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.963 | P0DP24 | CALM2 | Calmodulin-2 | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.963 | P0DP23 | CALM1 | Calmodulin-1 | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.828 | O15529 | GPR42 | G-protein coupled receptor 42 | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.728 | O14843 | FFAR3 | Free fatty acid receptor 3 | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.728 | P0DP25 | CALM3 | Calmodulin-3 | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.828 | P0DP24 | CALM2 | Calmodulin-2 | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.828 | P0DP24 | CALM2 | Calmodulin-2 | P17844 | DDX5 | Probable ATP-dependent RNA helicase DDX5 | 0.734 | O15182 | CETN3 | Centrin-3 | O14776 | TCERG1 | Transcription elongation regulator 1 | 0.758 | P0DP23 | CALM1 | Calmodulin-1 | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | 0.781 | P0DP25 | CALM3 | Calmodulin-3 | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | 0.781 | P0DP24 | CALM2 | Calmodulin-2 | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | 0.781 | O15529 | GPR42 | G-protein coupled receptor 42 | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.867 | O14843 | FFAR3 | Free fatty acid receptor 3 | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.867 | O15182 | CETN3 | Centrin-3 | O75940 | SMNDC1 | Survival of motor neuron-related-splicing factor 30 | 0.859 | O15182 | CETN3 | Centrin-3 | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | 0.701 | O15182 | CETN3 | Centrin-3 | P09651 | HNRNPA1 | Heterogeneous nuclear ribonucleoprotein A1 | 0.757 | P0DP24 | CALM2 | Calmodulin-2 | Q15365 | PCBP1 | Poly(rC)-binding protein 1 | 0.75 | O15182 | CETN3 | Centrin-3 | O75494 | FUSIP1 | Serine/arginine-rich splicing factor 10 | 0.85 | P0DP23 | CALM1 | Calmodulin-1 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.914 | P0DP25 | CALM3 | Calmodulin-3 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.914 | P0DP24 | CALM2 | Calmodulin-2 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.914 | P0DP23 | CALM1 | Calmodulin-1 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.841 | O15529 | GPR42 | G-protein coupled receptor 42 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.731 | O14843 | FFAR3 | Free fatty acid receptor 3 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.731 | P0DP25 | CALM3 | Calmodulin-3 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.841 | P0DP24 | CALM2 | Calmodulin-2 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.841 | P0DP23 | CALM1 | Calmodulin-1 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.784 | O15529 | GPR42 | G-protein coupled receptor 42 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.747 | O14843 | FFAR3 | Free fatty acid receptor 3 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.747 | P0DP25 | CALM3 | Calmodulin-3 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.784 | P0DP24 | CALM2 | Calmodulin-2 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.784 | P0DP23 | CALM1 | Calmodulin-1 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.804 | O15529 | GPR42 | G-protein coupled receptor 42 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.738 | O14843 | FFAR3 | Free fatty acid receptor 3 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.738 | P0DP25 | CALM3 | Calmodulin-3 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.804 | P0DP24 | CALM2 | Calmodulin-2 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.804 | O15182 | CETN3 | Centrin-3 | O95777 | LSM8 | U6 snRNA-associated Sm-like protein LSm8 | 0.723 | P0DP23 | CALM1 | Calmodulin-1 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | 0.748 | O15529 | GPR42 | G-protein coupled receptor 42 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.706 | O14843 | FFAR3 | Free fatty acid receptor 3 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.706 | P0DP25 | CALM3 | Calmodulin-3 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | 0.748 | P0DP24 | CALM2 | Calmodulin-2 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | 0.748 | O15182 | CETN3 | Centrin-3 | P61326 | MAGOH | Protein mago nashi homolog | 0.811 |
| Promethazine | hsa03050 | Proteasome | 5.53E-03 | 2 | P43686, P28070 | PSMC4, PSMB4 | More | | Promethazine | hsa03060 | Protein export | 4.46E-03 | 2 | Q15070, O76094 | OXA1L, SRP72 | More | | Promethazine | hsa03320 | PPAR signaling pathway | 2.18E-02 | 2 | O00767, Q02318 | SCD, CYP27A1 | More | | Promethazine | hsa03450 | Non-homologous end-joining | 2.63E-04 | 2 | Q9NP87, P13010 | POLM, XRCC5 | More | | Promethazine | hsa03460 | Fanconi anemia pathway | 3.70E-03 | 3 | Q9NPI8, O60673, Q9UNA4 | FANCF, REV3L, POLI | More | | Promethazine | hsa04010 | MAPK signaling pathway | 4.15E-02 | 1 | P04049 | RAF1 | More | | Promethazine | hsa04012 | ErbB signaling pathway | 1.82E-02 | 1 | P04049 | RAF1 | More | | Promethazine | hsa04014 | Ras signaling pathway | 1.42E-03 | 10 | P04049, P31751, P20827, P49767, Q13009, P17252, Q15311, P0DP23, P62873, P19174 | RAF1, AKT2, EFNA1, VEGFC, TIAM1, PRKCA, RALBP1, CALM1, GNB1, PLCG1 | More | | Promethazine | hsa04015 | Rap1 signaling pathway | 2.53E-04 | 13 | P04049, P20827, P49767, P25116, Q8TEU7, Q13009, Q08828, P51828, P31751, P0DP23, P08514, P17252, P19174 | RAF1, EFNA1, VEGFC, F2R, RAPGEF6, TIAM1, ADCY1, ADCY7, AKT2, CALM1, ITGA2B, PRKCA, PLCG1 | More | | Promethazine | hsa04020 | Calcium signaling pathway | 1.04E-06 | 11 | P27987, Q08828, Q13557, P17252, O15399, P19174, P61073, P0DP23, P51828, P23634, P49767 | ITPKB, ADCY1, CAMK2D, PRKCA, GRIN2D, PLCG1, CXCR4, CALM1, ADCY7, ATP2B4, VEGFC | More | | Promethazine | hsa04022 | cGMP-PKG signaling pathway | 6.45E-03 | 5 | P04049, P18848, Q8WYR1, P05141, P0DP24 | RAF1, ATF4, PIK3R5, SLC25A5, CALM2 | More | | Promethazine | hsa04024 | cAMP signaling pathway | 1.05E-04 | 14 | P49019, Q08828, P51828, P22694, P31751, P0DP23, P20020, P23634, P04049, Q13557, Q13370, P48058, O15399, Q13009 | HCAR3, ADCY1, ADCY7, PRKACB, AKT2, CALM1, ATP2B1, ATP2B4, RAF1, CAMK2D, PDE3B, GRIA4, GRIN2D, TIAM1 | More | | Promethazine | hsa04060 | Cytokine-cytokine receptor interaction | 1.78E-03 | 15 | P27930, P14778, P26842, Q13651, P48551, P25024, Q9UBD3, P47992, P02775, P09341, P32248, P51684, P18510, P09603, P01730 | IL1R2, IL1R1, CD27, IL10RA, IFNAR2, CXCR1, XCL2, XCL1, PPBP, CXCL1, CCR7, CCR6, IL1RN, CSF1, CD4 | More | | Promethazine | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.51E-03 | 6 | P51684, P32248, P09341, P02775, P47992, Q9UBD3 | CCR6, CCR7, CXCL1, PPBP, XCL1, XCL2 | More | | Promethazine | hsa04062 | Chemokine signaling pathway | 1.73E-04 | 21 | P51684, P25024, P25025, Q8NHW4, P47992, Q9UBD3, P07948, P19174, P62873, P63218, P50151, P49407, Q08881, Q08828, P51828, Q13009, P14598, P42224, P31751, P04049, P49841 | CCR6, CXCR1, CXCR2, CCL4L2, XCL1, XCL2, LYN, PLCG1, GNB1, GNG5, GNG10, ARRB1, ITK, ADCY1, ADCY7, TIAM1, NCF1, STAT1, AKT2, RAF1, GSK3B | More | | Promethazine | hsa04064 | NF-kappa B signaling pathway | 3.52E-05 | 13 | P10415, Q13489, P51617, Q13546, P01584, P29965, P19174, Q9UDY8, Q13077, P24522, O75293, Q8NHW4, Q9NQC7 | BCL2, BIRC3, IRAK1, RIPK1, IL1B, CD40LG, PLCG1, MALT1, TRAF1, GADD45A, GADD45B, CCL4L2, CYLD | More | | Promethazine | hsa04068 | FoxO signaling pathway | 2.14E-03 | 2 | P04049, Q96BR1 | RAF1, SGK3 | More | | Promethazine | hsa04070 | Phosphatidylinositol signaling system | 6.70E-05 | 8 | P19174, P0DP23, Q14643, P23743, P48426, O14732, P27987, P17252 | PLCG1, CALM1, ITPR1, DGKA, PIP4K2A, IMPA2, ITPKB, PRKCA | More | | Promethazine | hsa04071 | Sphingolipid signaling pathway | 5.27E-08 | 14 | P04049, P17252, P21453, Q9H228, P01375, Q13510, Q13362, Q16537, Q9BX95, Q16539, P04637, P10415, Q9UQC2, P01042 | RAF1, PRKCA, S1PR1, EDG8, TNF, ASAH1, PPP2R5C, PPP2R5E, SGPP1, MAPK14, TP53, BCL2, GAB2, KNG1 | More | | Promethazine | hsa04072 | Phospholipase D signaling pathway | 9.87E-03 | 9 | P04049, P31751, P19174, P17252, Q15438, Q08828, P51828, P23743, P00734 | RAF1, AKT2, PLCG1, PRKCA, PSCD1, ADCY1, ADCY7, DGKA, F2 | More | | Promethazine | hsa04080 | Neuroactive ligand-receptor interaction | 1.97E-02 | 5 | P28472, P21453, Q9H228, P21730, P07550 | GABRB3, S1PR1, EDG8, C5AR1, ADRB2 | More | | Promethazine | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | | Promethazine | hsa04140 | Autophagy - animal | 1.55E-03 | 11 | P31751, P04049, Q7L523, Q9NQL2, Q96RR4, O75460, Q14643, P10415, Q04759, Q96GC9, Q8TEV9 | AKT2, RAF1, RRAGA, RRAGD, CAMKK2, ERN1, ITPR1, BCL2, PRKCQ, TMEM49, SMCR8 | More | | Promethazine | hsa04141 | Protein processing in endoplasmic reticulum | 2.89E-06 | 9 | P18848, P30101, P49257, O60337, P60604, P11142, P07900, P08238, Q9H173 | ATF4, PDIA3, LMAN1, MARH6, UBE2G2, HSPA8, HSP90AA1, HSP90AB1, SIL1 | More | | Promethazine | hsa04144 | Endocytosis | 8.99E-03 | 12 | P11142, Q9H444, O43633, O75351, Q9NZZ3, Q15438, Q14161, P14784, Q96QK1, Q9UMY4, Q9Y5X3, Q9UNH7 | HSPA8, CHMP4B, CHMP2A, VPS4B, CHMP5, PSCD1, GIT2, IL2RB, VPS35, SNX12, SNX5, SNX6 | More | | Promethazine | hsa04145 | Phagosome | 4.33E-07 | 13 | P60709, P63261, Q15075, Q15080, P14598, Q13509, P68371, Q13488, P05164, P78380, O60603, P35443, P13765 | ACTB, ACTG1, EEA1, NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, MPO, OLR1, TLR2, THBS4, HLA-DOB | More | | Promethazine | hsa04146 | Peroxisome | 2.42E-02 | 5 | O43933, P56589, Q9UKG9, O75521, P33121 | PEX1, PEX3, CROT, ECI2, ACSL1 | More | | Promethazine | hsa04150 | mTOR signaling pathway | 2.32E-02 | 1 | P04049 | RAF1 | More | | Promethazine | hsa04151 | PI3K-Akt signaling pathway | 2.05E-04 | 21 | P62753, O43521, P27348, P20827, P49767, Q13362, P08238, Q8WYR1, P62873, P16144, P48551, P14784, P23458, P01568, P15336, P18848, P10415, P17252, Q16513, O00141, Q6ZUJ8 | RPS6, BCL2L11, YWHAQ, EFNA1, VEGFC, PPP2R5C, HSP90AB1, PIK3R5, GNB1, ITGB4, IFNAR2, IL2RB, JAK1, IFNA21, ATF2, ATF4, BCL2, PRKCA, PKN2, SGK, PIK3AP1 | More | | Promethazine | hsa04210 | Apoptosis | 2.75E-05 | 11 | O76075, P07384, P01375, Q9NR28, O75460, Q16548, O43521, P18848, P60709, P63261, P04049 | DFFB, CAPN1, TNF, DIABLO, ERN1, BCL2A1, BCL2L11, ATF4, ACTB, ACTG1, RAF1 | More | | Promethazine | hsa04213 | Longevity regulating pathway - multiple species | 2.85E-02 | 2 | Q9Y4H2, Q13547 | IRS2, HDAC1 | More | | Promethazine | hsa04217 | Necroptosis | 2.34E-14 | 23 | P01375, P01568, P23458, P48023, Q13489, Q9NQC7, P42224, Q14765, P07900, P08238, P15104, P05141, P01584, P0C0S5, Q6FI13, Q99878, P10415, Q13557, Q9H444, O43633, Q9NZZ3, O75351, Q08752 | TNF, IFNA21, JAK1, FASLG, BIRC3, CYLD, STAT1, STAT4, HSP90AA1, HSP90AB1, GLUL, SLC25A5, IL1B, H2AFZ, H2AC18; H2AC19, H2AC14, BCL2, CAMK2D, CHMP4B, CHMP2A, CHMP5, VPS4B, PPID | More | | Promethazine | hsa04218 | Cellular senescence | 2.49E-02 | 1 | P04049 | RAF1 | More | | Promethazine | hsa04261 | Adrenergic signaling in cardiomyocytes | 5.24E-08 | 15 | P09493, P07550, Q08828, P51828, P22694, P31751, P18848, Q13362, Q16537, P0DP23, Q13557, P17252, P10415, P20020, P23634 | TPM1, ADRB2, ADCY1, ADCY7, PRKACB, AKT2, ATF4, PPP2R5C, PPP2R5E, CALM1, CAMK2D, PRKCA, BCL2, ATP2B1, ATP2B4 | More | | Promethazine | hsa04270 | Vascular smooth muscle contraction | 2.32E-02 | 1 | P04049 | RAF1 | More | | Promethazine | hsa04340 | Hedgehog signaling pathway | 3.32E-02 | 2 | P49841, P22694 | GSK3B, PRKACB | More | | Promethazine | hsa04350 | TGF-beta signaling pathway | 4.88E-02 | 1 | P37173 | TGFBR2 | More | | Promethazine | hsa04360 | Axon guidance | 3.05E-04 | 9 | P61073, P16333, P20827, O95631, P17252, Q13557, P23528, P04049, P19174 | CXCR4, NCK1, EFNA1, NTN1, PRKCA, CAMK2D, CFL1, RAF1, PLCG1 | More | | Promethazine | hsa04370 | VEGF signaling pathway | 8.29E-03 | 1 | P04049 | RAF1 | More | | Promethazine | hsa04371 | Apelin signaling pathway | 1.61E-02 | 8 | P62873, P31751, P04049, Q08828, P51828, Q13370, Q13485, P0DP23 | GNB1, AKT2, RAF1, ADCY1, ADCY7, PDE3B, SMAD4, CALM1 | More | | Promethazine | hsa04380 | Osteoclast differentiation | 4.18E-02 | 7 | Q9NQC7, Q9UQC2, P23458, P42224, P01584, Q15080, P14598 | CYLD, GAB2, JAK1, STAT1, IL1B, NCF4, NCF1 | More | | Promethazine | hsa04390 | Hippo signaling pathway | 2.80E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Promethazine | hsa04510 | Focal adhesion | 1.26E-02 | 8 | P16144, O75369, Q15942, P17252, Q13489, P10415, P04049, P49767 | ITGB4, FLNB, ZYX, PRKCA, BIRC3, BCL2, RAF1, VEGFC | More | | Promethazine | hsa04520 | Adherens junction | 8.79E-04 | 4 | P37173, P24666, P60709, P63261 | TGFBR2, ACP1, ACTB, ACTG1 | More | | Promethazine | hsa04530 | Tight junction | 6.83E-04 | 6 | P60709, P63261, P16989, P56750, Q14247, P60660 | ACTB, ACTG1, CSDA, CLDN17, CTTN, MYL6 | More | | Promethazine | hsa04540 | Gap junction | 9.65E-04 | 7 | P17252, Q13509, P68371, Q08828, P51828, P04049, Q14643 | PRKCA, TUBB3, TUBB2C, ADCY1, ADCY7, RAF1, ITPR1 | More | | Promethazine | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 1.99E-02 | 1 | P04049 | RAF1 | More | | Promethazine | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | | Promethazine | hsa04611 | Platelet activation | 2.98E-03 | 5 | P25116, P08514, P60709, P63261, P07359 | F2R, ITGA2B, ACTB, ACTG1, GP1BA | More | | Promethazine | hsa04612 | Antigen processing and presentation | 5.58E-07 | 10 | P13765, P48382, Q14953, P26715, P26717, Q07444, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KIR2DS5, KLRC1, KLRC2, KLRC3, KLRD1, KLRC4, CD8A, TNF | More | | Promethazine | hsa04613 | Neutrophil extracellular trap formation | 1.17E-08 | 27 | P17252, P04049, P11215, O60603, P05164, P08246, Q9UM07, Q13547, Q92769, P04908, Q6FI13, Q93077, P58876, P62807, P33778, Q16778, O60814, P68431, P14598, Q15080, P20160, P08311, O75015, P21730, P21462, O43315, Q16539 | PRKCA, RAF1, ITGAM, TLR2, MPO, ELA2, PADI4, HDAC1, HDAC2, H2AC4; H2AC8, H2AC18; H2AC19, HIST1H2AC, H2BC5, HIST1H2BC, H2BC3, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF1, NCF4, AZU1, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Promethazine | hsa04614 | Renin-angiotensin system | 1.52E-02 | 1 | P50052 | AGTR2 | More | | Promethazine | hsa04620 | Toll-like receptor signaling pathway | 1.33E-02 | 5 | P51617, P01568, P31751, P42224, Q8NHW4 | IRAK1, IFNA21, AKT2, STAT1, CCL4L2 | More | | Promethazine | hsa04621 | NOD-like receptor signaling pathway | 3.16E-02 | 9 | P01584, P08238, P23458, P42224, P01568, Q9H3M7, Q13489, P43490, P10415 | IL1B, HSP90AB1, JAK1, STAT1, IFNA21, TXNIP, BIRC3, PBEF1, BCL2 | More | | Promethazine | hsa04623 | Cytosolic DNA-sensing pathway | 4.52E-03 | 3 | P01568, Q13546, Q8NHW4 | IFNA21, RIPK1, CCL4L2 | More | | Promethazine | hsa04625 | C-type lectin receptor signaling pathway | 1.49E-02 | 1 | P04049 | RAF1 | More | | Promethazine | hsa04630 | JAK-STAT signaling pathway | 1.77E-03 | 9 | P31751, P10415, P42224, P23458, P14784, P16871, Q13651, P04049, P01568 | AKT2, BCL2, STAT1, JAK1, IL2RB, IL7R, IL10RA, RAF1, IFNA21 | More | | Promethazine | hsa04640 | Hematopoietic cell lineage | 2.29E-06 | 12 | P13612, P08514, P21926, P14778, P27930, P25063, P07766, P01732, P01730, P09564, P13765, P09603 | ITGA4, ITGA2B, CD9, IL1R1, IL1R2, CD24, CD3E, CD8A, CD4, CD7, HLA-DOB, CSF1 | More | | Promethazine | hsa04650 | Natural killer cell mediated cytotoxicity | 2.29E-13 | 15 | P01375, P17252, P78314, P06239, O60880, P20963, P04049, Q13241, P26718, O14931, O75015, P26717, Q07444, Q14953, P26715 | TNF, PRKCA, SH3BP2, LCK, SH2D1A, CD247, RAF1, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KLRC3, KIR2DS5, KLRC1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P07550 | ADRB2 | Beta-2 adrenergic receptor | P01375 | TNF | Tumor necrosis factor | -0.755 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P01375 | TNF | Tumor necrosis factor | 0.718 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | P17252 | PRKCA | Protein kinase C alpha type | -0.727 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P78314 | SH3BP2 | SH3 domain-binding protein 2 | 0.748 | O14626 | GPR171 | Probable G-protein coupled receptor 171 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.864 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.779 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.71 | O14626 | GPR171 | Probable G-protein coupled receptor 171 | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.92 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.751 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.788 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.727 | O14626 | GPR171 | Probable G-protein coupled receptor 171 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.898 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.722 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.771 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P07550 | ADRB2 | Beta-2 adrenergic receptor | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.838 | O14626 | GPR171 | Probable G-protein coupled receptor 171 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.809 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.715 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.701 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.701 | O14626 | GPR171 | Probable G-protein coupled receptor 171 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.818 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.842 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.81 | O14626 | GPR171 | Probable G-protein coupled receptor 171 | O14931 | NCR3 | Natural cytotoxicity triggering receptor 3 | 0.765 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.913 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.896 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.717 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.72 | O14626 | GPR171 | Probable G-protein coupled receptor 171 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.826 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.714 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.721 | O14626 | GPR171 | Probable G-protein coupled receptor 171 | Q07444 | KLRC3 | NKG2-E type II integral membrane protein | 0.761 | P07550 | ADRB2 | Beta-2 adrenergic receptor | Q14953 | KIR2DS5 | Killer cell immunoglobulin-like receptor 2DS5 | 0.815 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.717 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.72 | O14626 | GPR171 | Probable G-protein coupled receptor 171 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.826 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.714 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.721 |
| Promethazine | hsa04657 | IL-17 signaling pathway | 5.66E-05 | 10 | P07900, O00463, Q16539, P49841, P19875, P14780, Q9UJX4, P80188, P01375, P01584 | HSP90AA1, TRAF5, MAPK14, GSK3B, CXCL2, MMP9, ANAPC5, LCN2, TNF, IL1B | More | | Promethazine | hsa04658 | Th1 and Th2 cell differentiation | 1.98E-08 | 11 | Q04759, P07766, P20963, P09693, P01730, P06239, Q14765, P23771, Q9UL17, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, CD4, LCK, STAT4, GATA3, TBX21, HLA-DOB, RUNX3 | More | | Promethazine | hsa04659 | Th17 cell differentiation | 4.42E-06 | 11 | Q04759, P01730, P06239, P13765, P14778, Q9HBE5, Q9UL17, P23771, P07766, P09693, P20963 | PRKCQ, CD4, LCK, HLA-DOB, IL1R1, IL21R, TBX21, GATA3, CD3E, CD3G, CD247 | More | | Promethazine | hsa04660 | T cell receptor signaling pathway | 7.60E-07 | 13 | P01375, Q04759, O95267, Q08881, P07766, P20963, P09693, P01732, Q13191, P06239, P04049, Q16539, P49841 | TNF, PRKCQ, RASGRP1, ITK, CD3E, CD247, CD3G, CD8A, CBLB, LCK, RAF1, MAPK14, GSK3B | More | | Promethazine | hsa04662 | B cell receptor signaling pathway | 2.13E-03 | 3 | P25963, P20023, P04049 | NFKBIA, CR2, RAF1 | More | | Promethazine | hsa04664 | Fc epsilon RI signaling pathway | 1.16E-02 | 1 | P04049 | RAF1 | More | | Promethazine | hsa04666 | Fc gamma R-mediated phagocytosis | 5.45E-05 | 10 | P08575, P19174, P04049, P23528, P49006, P06396, O14494, Q9UQC2, P14598, P17252 | PTPRC, PLCG1, RAF1, CFL1, MARCKSL1, GSN, PLPP1, GAB2, NCF1, PRKCA | More | | Promethazine | hsa04668 | TNF signaling pathway | 2.67E-03 | 6 | P01375, P18848, P19875, P01584, P14780, P20333 | TNF, ATF4, CXCL2, IL1B, MMP9, TNFRSF1B | More | | Promethazine | hsa04670 | Leukocyte transendothelial migration | 4.07E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Promethazine | hsa04672 | Intestinal immune network for IgA production | 1.35E-02 | 2 | P29965, P13765 | CD40LG, HLA-DOB | More | | Promethazine | hsa04713 | Circadian entrainment | 4.27E-06 | 9 | O15399, P0DP23, Q13557, P17252, P62873, P48058, Q08828, P51828, P22694 | GRIN2D, CALM1, CAMK2D, PRKCA, GNB1, GRIA4, ADCY1, ADCY7, PRKACB | More | | Promethazine | hsa04714 | Thermogenesis | 5.98E-06 | 9 | P22694, Q16539, P15336, P60709, P63261, P33121, Q16718, O14521, P36542 | PRKACB, MAPK14, ATF2, ACTB, ACTG1, ACSL1, NDUFA5, SDHD, ATP5C1 | More | | Promethazine | hsa04720 | Long-term potentiation | 9.95E-06 | 9 | P17252, Q16566, Q13557, P0DP23, P18848, O15399, Q08828, P04049, Q14643 | PRKCA, CAMK4, CAMK2D, CALM1, ATF4, GRIN2D, ADCY1, RAF1, ITPR1 | More | | Promethazine | hsa04721 | Synaptic vesicle cycle | 1.14E-02 | 2 | Q13488, P31645 | TCIRG1, SLC6A4 | More | | Promethazine | hsa04722 | Neurotrophin signaling pathway | 7.10E-03 | 4 | P04049, P49841, O43524, P48023 | RAF1, GSK3B, FOXO3, FASLG | More | | Promethazine | hsa04723 | Retrograde endocannabinoid signaling | 3.01E-04 | 6 | Q14643, P17252, P62873, P48058, P22694, Q16718 | ITPR1, PRKCA, GNB1, GRIA4, PRKACB, NDUFA5 | More | | Promethazine | hsa04724 | Glutamatergic synapse | 3.62E-06 | 11 | P48058, O15399, P43003, Q08828, P51828, P22694, P17252, P62873, P63218, P50151, P15104 | GRIA4, GRIN2D, SLC1A3, ADCY1, ADCY7, PRKACB, PRKCA, GNB1, GNG5, GNG10, GLUL | More | | Promethazine | hsa04725 | Cholinergic synapse | 1.21E-05 | 10 | Q08828, P51828, Q14643, P17252, P62873, P18848, Q16566, Q13557, P31751, P10415 | ADCY1, ADCY7, ITPR1, PRKCA, GNB1, ATF4, CAMK4, CAMK2D, AKT2, BCL2 | More | | Promethazine | hsa04726 | Serotonergic synapse | 1.74E-04 | 5 | P22694, P17252, P31645, P11712, P04049 | PRKACB, PRKCA, SLC6A4, CYP2C9, RAF1 | More | | Promethazine | hsa04727 | GABAergic synapse | 5.77E-04 | 8 | Q08828, P51828, P62873, P63218, P50151, P15104, P46459, P17252 | ADCY1, ADCY7, GNB1, GNG5, GNG10, GLUL, NSF, PRKCA | More | | Promethazine | hsa04728 | Dopaminergic synapse | 2.82E-02 | 6 | P14416, P63218, P50151, P49841, Q16539, P49407 | DRD2, GNG5, GNG10, GSK3B, MAPK14, ARRB1 | More | | Promethazine | hsa04730 | Long-term depression | 1.25E-04 | 3 | Q14344, P04049, P07948 | GNA13, RAF1, LYN | More | | Promethazine | hsa04740 | Olfactory transduction | 5.88E-03 | 4 | P62873, Q9H255, Q13557, P0DP23 | GNB1, OR51E2, CAMK2D, CALM1 | More | | Promethazine | hsa04742 | Taste transduction | 1.01E-02 | 1 | P30939 | HTR1F | More | | Promethazine | hsa04744 | Phototransduction | 2.72E-07 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Promethazine | hsa04750 | Inflammatory mediator regulation of TRP channels | 6.11E-06 | 11 | P01584, Q08828, P51828, P22694, Q13557, P19174, P17252, P24723, Q04759, P0DP23, P01042 | IL1B, ADCY1, ADCY7, PRKACB, CAMK2D, PLCG1, PRKCA, PRKCH, PRKCQ, CALM1, KNG1 | More | | Promethazine | hsa04810 | Regulation of actin cytoskeleton | 3.81E-02 | 1 | P04049 | RAF1 | More | | Promethazine | hsa04910 | Insulin signaling pathway | 2.51E-03 | 4 | P22694, P06737, P04049, P49841 | PRKACB, PYGL, RAF1, GSK3B | More | | Promethazine | hsa04911 | Insulin secretion | 3.01E-03 | 5 | Q08828, P22694, P17252, P18848, Q13557 | ADCY1, PRKACB, PRKCA, ATF4, CAMK2D | More | | Promethazine | hsa04912 | GnRH signaling pathway | 2.10E-03 | 7 | P17252, Q08828, P18848, Q13557, Q14643, P0DP23, P04049 | PRKCA, ADCY1, ATF4, CAMK2D, ITPR1, CALM1, RAF1 | More | | Promethazine | hsa04913 | Ovarian steroidogenesis | 3.71E-05 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | | Promethazine | hsa04914 | Progesterone-mediated oocyte maturation | 1.53E-02 | 7 | Q08828, P51828, P31751, Q13370, Q9UJX4, P08238, P04049 | ADCY1, ADCY7, AKT2, PDE3B, ANAPC5, HSP90AB1, RAF1 | More | | Promethazine | hsa04915 | Estrogen signaling pathway | 2.35E-03 | 10 | P04049, P18848, Q08828, P51828, P31751, P08238, P11142, P0DP23, Q15788, P10415 | RAF1, ATF4, ADCY1, ADCY7, AKT2, HSP90AB1, HSPA8, CALM1, NCOA1, BCL2 | More | | Promethazine | hsa04916 | Melanogenesis | 5.38E-03 | 5 | P0DP23, Q9UJU2, P17252, P04628, P04049 | CALM1, LEF1, PRKCA, WNT1, RAF1 | More | | Promethazine | hsa04917 | Prolactin signaling pathway | 6.63E-03 | 1 | P04049 | RAF1 | More | | Promethazine | hsa04918 | Thyroid hormone synthesis | 1.94E-03 | 3 | P22694, P17252, P27824 | PRKACB, PRKCA, CANX | More | | Promethazine | hsa04919 | Thyroid hormone signaling pathway | 6.15E-05 | 7 | P49841, P04049, P22694, P60709, P63261, O60244, Q9NVC6 | GSK3B, RAF1, PRKACB, ACTB, ACTG1, MED14, MED17 | More | | Promethazine | hsa04921 | Oxytocin signaling pathway | 1.43E-04 | 4 | P04049, P60660, P60709, P63261 | RAF1, MYL6, ACTB, ACTG1 | More | | Promethazine | hsa04923 | Regulation of lipolysis in adipocytes | 2.12E-02 | 4 | Q08828, P51828, Q13370, P31751 | ADCY1, ADCY7, PDE3B, AKT2 | More | | Promethazine | hsa04924 | Renin secretion | 4.04E-02 | 2 | P22694, P07550 | PRKACB, ADRB2 | More | | Promethazine | hsa04925 | Aldosterone synthesis and secretion | 1.35E-07 | 11 | Q14643, P18848, Q08828, P51828, P0DP23, P17252, Q16566, Q13557, P22694, P20020, P23634 | ITPR1, ATF4, ADCY1, ADCY7, CALM1, PRKCA, CAMK4, CAMK2D, PRKACB, ATP2B1, ATP2B4 | More | | Promethazine | hsa04926 | Relaxin signaling pathway | 6.24E-03 | 5 | P18848, P22694, P14780, P04049, P30679 | ATF4, PRKACB, MMP9, RAF1, GNA15 | More | | Promethazine | hsa04927 | Cortisol synthesis and secretion | 2.54E-02 | 2 | P18848, P22694 | ATF4, PRKACB | More | | Promethazine | hsa04928 | Parathyroid hormone synthesis, secretion and action | 1.99E-02 | 1 | P04049 | RAF1 | More | | Promethazine | hsa04929 | GnRH secretion | 4.98E-03 | 1 | P04049 | RAF1 | More | | Promethazine | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | | Promethazine | hsa04932 | Non-alcoholic fatty liver disease | 4.65E-07 | 11 | P01375, P49841, O43521, P18848, P48023, O75460, P01584, P13073, O15239, Q16718, O14521 | TNF, GSK3B, BCL2L11, ATF4, FASLG, ERN1, IL1B, COX4I1, NDUFA1, NDUFA5, SDHD | More | | Promethazine | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 2.04E-06 | 8 | Q13485, P01584, P42224, P10415, P31751, P49767, P17252, P19174 | SMAD4, IL1B, STAT1, BCL2, AKT2, VEGFC, PRKCA, PLCG1 | More | | Promethazine | hsa04935 | Growth hormone synthesis, secretion and action | 1.77E-02 | 7 | P19174, Q08828, P51828, P04049, P17252, P31751, P42224 | PLCG1, ADCY1, ADCY7, RAF1, PRKCA, AKT2, STAT1 | More | | Promethazine | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Promethazine | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 9.85E-05 | 3 | P20020, P17252, P22694 | ATP2B1, PRKCA, PRKACB | More | | Promethazine | hsa04962 | Vasopressin-regulated water reabsorption | 6.61E-03 | 2 | P22694, Q13561 | PRKACB, DCTN2 | More | | Promethazine | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Promethazine | hsa04966 | Collecting duct acid secretion | 8.43E-06 | 4 | Q13488, P02730, P00918, Q9Y666 | TCIRG1, SLC4A1, CA2, SLC12A7 | More | | Promethazine | hsa04970 | Salivary secretion | 1.17E-07 | 10 | P07550, Q08828, P51828, P22694, Q14643, P20020, P23634, P17252, P0DP23, P49913 | ADRB2, ADCY1, ADCY7, PRKACB, ITPR1, ATP2B1, ATP2B4, PRKCA, CALM1, CAMP | More | | Promethazine | hsa04971 | Gastric acid secretion | 1.02E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Promethazine | hsa04972 | Pancreatic secretion | 4.64E-07 | 7 | Q14643, P20020, P23634, P17252, Q08828, P51828, P62491 | ITPR1, ATP2B1, ATP2B4, PRKCA, ADCY1, ADCY7, RAB11A | More | | Promethazine | hsa04976 | Bile secretion | 1.16E-04 | 3 | O43315, P22694, P08183 | AQP9, PRKACB, ABCB1 | More | | Promethazine | hsa05010 | Alzheimer disease | 6.24E-04 | 12 | O15239, P13073, O75460, P0DP24, P01584, P18848, O15169, P67870, P05141, P12236, P28070, P43686 | NDUFA1, COX4I1, ERN1, CALM2, IL1B, ATF4, AXIN1, CSNK2B, SLC25A5, SLC25A6, PSMB4, PSMC4 | More | | Promethazine | hsa05012 | Parkinson disease | 7.75E-07 | 14 | O15239, P13073, P05141, P12236, P21796, P60604, O75460, P18848, P28070, P43686, P0DP24, Q13557, Q71U36, Q13509 | NDUFA1, COX4I1, SLC25A5, SLC25A6, VDAC1, UBE2G2, ERN1, ATF4, PSMB4, PSMC4, CALM2, CAMK2D, TUBA1A, TUBB3 | More | | Promethazine | hsa05014 | Amyotrophic lateral sclerosis | 2.98E-02 | 3 | P36542, P60709, P63261 | ATP5C1, ACTB, ACTG1 | More | | Promethazine | hsa05016 | Huntington disease | 1.34E-05 | 10 | O15239, P13073, Q9GZM3, P24928, P30876, P62487, P52435, P05141, Q9NYC9, O75460 | NDUFA1, COX4I1, POLR2J2, POLR2A, POLR2B, POLR2G, POLR2J, SLC25A5, DNAH9, ERN1 | More | | Promethazine | hsa05017 | Spinocerebellar ataxia | 4.93E-04 | 10 | P17252, O75460, Q8TB72, O15399, P31751, P28070, P43686, O00232, P05141, P12236 | PRKCA, ERN1, PUM2, GRIN2D, AKT2, PSMB4, PSMC4, PSMD12, SLC25A5, SLC25A6 | More | | Promethazine | hsa05020 | Prion disease | 6.37E-09 | 24 | P13591, P01584, P46531, P11142, O15239, Q16718, O14521, P13073, Q14643, P18848, P05141, P12236, P21796, P28070, P43686, Q71U36, Q13509, P68371, P49841, P67870, P51636, P14598, Q15080, Q16539 | NCAM1, IL1B, NOTCH1, HSPA8, NDUFA1, NDUFA5, SDHD, COX4I1, ITPR1, ATF4, SLC25A5, SLC25A6, VDAC1, PSMB4, PSMC4, TUBA1A, TUBB3, TUBB2C, GSK3B, CSNK2B, CAV2, NCF1, NCF4, MAPK14 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P02768 | ALB | Albumin | P13591 | NCAM1 | Neural cell adhesion molecule 1 | 0.701 | P02768 | ALB | Albumin | P01584 | IL1B | Interleukin-1 beta | 0.718 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P46531 | NOTCH1 | Neurogenic locus notch homolog protein 1 | 0.75 | P02768 | ALB | Albumin | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.72 | O15529 | GPR42 | G-protein coupled receptor 42 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.738 | O14843 | FFAR3 | Free fatty acid receptor 3 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.738 | P02768 | ALB | Albumin | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.723 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.753 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.709 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.757 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.719 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.732 | P02768 | ALB | Albumin | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.747 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.839 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.793 | P02768 | ALB | Albumin | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.88 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.742 | P02768 | ALB | Albumin | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.81 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.721 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P12236 | SLC25A6 | ADP/ATP translocase 3 | 0.766 | O15529 | GPR42 | G-protein coupled receptor 42 | P21796 | VDAC1 | Voltage-dependent anion-selective channel protein 1 | -0.739 | O14843 | FFAR3 | Free fatty acid receptor 3 | P21796 | VDAC1 | Voltage-dependent anion-selective channel protein 1 | -0.739 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.73 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P43686 | PSMC4 | 26S proteasome regulatory subunit 6B | 0.835 | O15529 | GPR42 | G-protein coupled receptor 42 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | 0.861 | O14843 | FFAR3 | Free fatty acid receptor 3 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | 0.861 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.787 | O15529 | GPR42 | G-protein coupled receptor 42 | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.72 | O14843 | FFAR3 | Free fatty acid receptor 3 | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.72 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | P68371 | TUBB2C | Tubulin beta-4B chain | -0.908 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.714 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P67870 | CSNK2B | Casein kinase II subunit beta | 0.733 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P51636 | CAV2 | Caveolin-2 | -0.75 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.851 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.871 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 |
| Promethazine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 9.56E-10 | 31 | Q14643, Q71U36, Q13509, P68371, P49841, P67870, P10415, O15239, Q16718, O14521, P13073, P21796, O75460, P18848, Q13561, P48058, P05141, P12236, P17252, P20333, Q16539, O15169, P04628, P01584, Q08752, P0DP23, P0DP24, Q13557, P28070, P43686, P60604 | ITPR1, TUBA1A, TUBB3, TUBB2C, GSK3B, CSNK2B, BCL2, NDUFA1, NDUFA5, SDHD, COX4I1, VDAC1, ERN1, ATF4, DCTN2, GRIA4, SLC25A5, SLC25A6, PRKCA, TNFRSF1B, MAPK14, AXIN1, WNT1, IL1B, PPID, CALM1, CALM2, CAMK2D, PSMB4, PSMC4, UBE2G2 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O00398 | P2RY10 | Putative P2Y purinoceptor 10 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.793 | O15529 | GPR42 | G-protein coupled receptor 42 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | 0.861 | O14843 | FFAR3 | Free fatty acid receptor 3 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | 0.861 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.787 | O15529 | GPR42 | G-protein coupled receptor 42 | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.72 | O14843 | FFAR3 | Free fatty acid receptor 3 | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.72 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | P68371 | TUBB2C | Tubulin beta-4B chain | -0.908 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.714 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P67870 | CSNK2B | Casein kinase II subunit beta | 0.733 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.919 | P02768 | ALB | Albumin | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.723 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.753 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.709 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | -0.837 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.757 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.719 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.732 | P02768 | ALB | Albumin | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.747 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.839 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.717 | O15529 | GPR42 | G-protein coupled receptor 42 | P21796 | VDAC1 | Voltage-dependent anion-selective channel protein 1 | -0.739 | O14843 | FFAR3 | Free fatty acid receptor 3 | P21796 | VDAC1 | Voltage-dependent anion-selective channel protein 1 | -0.739 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.702 | P02768 | ALB | Albumin | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.88 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.742 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.723 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | Q13561 | DCTN2 | Dynactin subunit 2 | -0.876 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | Q13561 | DCTN2 | Dynactin subunit 2 | 0.812 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q13561 | DCTN2 | Dynactin subunit 2 | -0.771 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | P48058 | GRIA4 | Glutamate receptor 4 | 0.707 | P02768 | ALB | Albumin | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.81 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.721 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.797 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P12236 | SLC25A6 | ADP/ATP translocase 3 | 0.766 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | P17252 | PRKCA | Protein kinase C alpha type | 0.887 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | P17252 | PRKCA | Protein kinase C alpha type | -0.727 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P20333 | TNFRSF1B | Tumor necrosis factor receptor superfamily member 1B | 0.879 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P20333 | TNFRSF1B | Tumor necrosis factor receptor superfamily member 1B | 0.706 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | O15169 | AXIN1 | Axin-1 | 0.712 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | P04628 | WNT1 | Proto-oncogene Wnt-1 | 0.732 | O15529 | GPR42 | G-protein coupled receptor 42 | P04628 | WNT1 | Proto-oncogene Wnt-1 | 0.711 | O14843 | FFAR3 | Free fatty acid receptor 3 | P04628 | WNT1 | Proto-oncogene Wnt-1 | 0.711 | P02768 | ALB | Albumin | P01584 | IL1B | Interleukin-1 beta | 0.718 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P01584 | IL1B | Interleukin-1 beta | 0.825 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | -0.804 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | 0.859 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | P0DP23 | CALM1 | Calmodulin-1 | -0.815 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P0DP24 | CALM2 | Calmodulin-2 | 0.759 | P02768 | ALB | Albumin | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.75 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.73 | Q9ULS6 | KCNS2 | Potassium voltage-gated channel subfamily S member 2 | P43686 | PSMC4 | 26S proteasome regulatory subunit 6B | 0.835 | O15529 | GPR42 | G-protein coupled receptor 42 | P60604 | UBE2G2 | Ubiquitin-conjugating enzyme E2 G2 | -0.7 | O14843 | FFAR3 | Free fatty acid receptor 3 | P60604 | UBE2G2 | Ubiquitin-conjugating enzyme E2 G2 | -0.7 |
| Promethazine | hsa05031 | Amphetamine addiction | 2.55E-04 | 8 | O15399, P48058, P0DP23, Q13557, P22694, P18848, P17252, Q13547 | GRIN2D, GRIA4, CALM1, CAMK2D, PRKACB, ATF4, PRKCA, HDAC1 | More | | Promethazine | hsa05032 | Morphine addiction | 4.08E-02 | 5 | Q08828, P51828, P62873, Q13370, P17252 | ADCY1, ADCY7, GNB1, PDE3B, PRKCA | More | | Promethazine | hsa05034 | Alcoholism | 1.81E-06 | 8 | Q13547, P04049, Q93077, P58876, P62807, Q16778, O60814, P68431 | HDAC1, RAF1, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Promethazine | hsa05100 | Bacterial invasion of epithelial cells | 8.79E-04 | 3 | P60709, P63261, Q92529 | ACTB, ACTG1, SHC3 | More | | Promethazine | hsa05110 | Vibrio cholerae infection | 4.61E-04 | 4 | P17252, P22694, P60709, P63261 | PRKCA, PRKACB, ACTB, ACTG1 | More | | Promethazine | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 3.11E-02 | 4 | Q16539, P25024, P25025, P07948 | MAPK14, CXCR1, CXCR2, LYN | More | | Promethazine | hsa05131 | Shigellosis | 1.91E-02 | 3 | P60709, P63261, P07384 | ACTB, ACTG1, CAPN1 | More | | Promethazine | hsa05132 | Salmonella infection | 1.47E-07 | 19 | P51617, P01584, P08238, P04049, Q9UJU2, Q96RF0, Q13546, Q13489, P10415, P08575, O75369, O60603, Q9BQS8, P51808, Q13561, Q13509, P68371, P49754, Q9NP90 | IRAK1, IL1B, HSP90AB1, RAF1, LEF1, SNAG1, RIPK1, BIRC3, BCL2, PTPRC, FLNB, TLR2, FYCO1, DYNLT3, DCTN2, TUBB3, TUBB2C, VPS41, RAB9B | More | | Promethazine | hsa05133 | Pertussis | 6.00E-05 | 6 | P0DP23, P01584, P23528, P09871, P0C0L4, P51617 | CALM1, IL1B, CFL1, C1S, C4A, IRAK1 | More | | Promethazine | hsa05134 | Legionellosis | 1.28E-02 | 3 | P01584, P68104, P11142 | IL1B, EEF1A1, HSPA8 | More | | Promethazine | hsa05135 | Yersinia infection | 5.31E-03 | 8 | P60709, P63261, Q16513, P13612, P06239, Q16539, P01375, P49841 | ACTB, ACTG1, PKN2, ITGA4, LCK, MAPK14, TNF, GSK3B | More | | Promethazine | hsa05140 | Leishmaniasis | 1.10E-03 | 7 | P14598, O60603, P25963, P29350, P49006, P51617, Q15080 | NCF1, TLR2, NFKBIA, PTPN6, MARCKSL1, IRAK1, NCF4 | More | | Promethazine | hsa05143 | African trypanosomiasis | 1.93E-04 | 7 | P01375, P01584, P69905, P68871, P48023, P17252, P01042 | TNF, IL1B, HBA2, HBB, FASLG, PRKCA, KNG1 | More | | Promethazine | hsa05144 | Malaria | 1.30E-05 | 7 | P60033, P69905, P68871, O60603, P01375, P35443, P26718 | CD81, HBA2, HBB, TLR2, TNF, THBS4, KLRK1 | More | | Promethazine | hsa05145 | Toxoplasmosis | 5.28E-05 | 9 | P51617, P10415, Q13489, P23458, P42224, P31751, P11142, P29965, Q13651 | IRAK1, BCL2, BIRC3, JAK1, STAT1, AKT2, HSPA8, CD40LG, IL10RA | More | | Promethazine | hsa05146 | Amoebiasis | 9.63E-07 | 11 | Q13751, P09341, P19875, P14778, P27930, P01375, P05089, P30679, P22694, P12814, P08311 | LAMB3, CXCL1, CXCL2, IL1R1, IL1R2, TNF, ARG1, GNA15, PRKACB, ACTN1, CTSG | More | | Promethazine | hsa05152 | Tuberculosis | 4.21E-03 | 9 | P04049, Q13488, P0DP23, P48382, O60603, P10415, P13765, P01568, Q9UDY8 | RAF1, TCIRG1, CALM1, RFX5, TLR2, BCL2, HLA-DOB, IFNA21, MALT1 | More | | Promethazine | hsa05160 | Hepatitis C | 1.40E-03 | 5 | P60033, P04049, P49841, P01375, P48023 | CD81, RAF1, GSK3B, TNF, FASLG | More | | Promethazine | hsa05161 | Hepatitis B | 2.85E-05 | 11 | P17252, P04049, P18848, P23458, Q13485, P31751, P10415, P27348, P01568, P42224, P51617 | PRKCA, RAF1, ATF4, JAK1, SMAD4, AKT2, BCL2, YWHAQ, IFNA21, STAT1, IRAK1 | More | | Promethazine | hsa05162 | Measles | 2.45E-05 | 10 | P51617, P01568, P23458, P42224, P14784, P31751, P11142, P01584, Q9NP90, P10415 | IRAK1, IFNA21, JAK1, STAT1, IL2RB, AKT2, HSPA8, IL1B, RAB9B, BCL2 | More | | Promethazine | hsa05163 | Human cytomegalovirus infection | 2.26E-04 | 23 | P31751, P04049, P01375, P62873, P63218, P50151, P0DP23, Q8NHW4, Q08828, P51828, P23458, P49841, P14778, P01584, P61073, P17252, Q13651, P25025, Q16539, P18848, O00463, P61769, P01568 | AKT2, RAF1, TNF, GNB1, GNG5, GNG10, CALM1, CCL4L2, ADCY1, ADCY7, JAK1, GSK3B, IL1R1, IL1B, CXCR4, PRKCA, IL10RA, CXCR2, MAPK14, ATF4, TRAF5, B2M, IFNA21 | More | | Promethazine | hsa05164 | Influenza A | 8.97E-04 | 4 | P48551, P04049, P60709, P63261 | IFNAR2, RAF1, ACTB, ACTG1 | More | | Promethazine | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 3.15E-02 | 1 | P04049 | RAF1 | More | | Promethazine | hsa05168 | Herpes simplex virus 1 infection | 2.45E-05 | 18 | P01568, P01584, Q9UBU9, P23458, P42224, Q07955, Q01130, Q13243, Q13489, P51617, P61769, P31751, Q13398, Q6P280, Q03923, Q9UDV6, P10415, Q14232 | IFNA21, IL1B, NXF1, JAK1, STAT1, SFRS1, SFRS2, SFRS5, BIRC3, IRAK1, B2M, AKT2, ZNF211, ZNF529, ZNF85, ZNF212, BCL2, EIF2B1 | More | | Promethazine | hsa05169 | Epstein-Barr virus infection | 3.06E-03 | 11 | P13765, Q92769, P04637, Q13546, P10415, P24522, P48551, O60603, P29728, P51617, P09693 | HLA-DOB, HDAC2, TP53, RIPK1, BCL2, GADD45A, IFNAR2, TLR2, OAS2, IRAK1, CD3G | More | | Promethazine | hsa05170 | Human immunodeficiency virus 1 infection | 8.74E-09 | 17 | P31751, P04049, P62873, P0DP23, P61073, P17252, Q13546, P61769, Q14643, P01568, P51617, O60603, P19174, P23528, P09693, P10415, Q9Y6Q5 | AKT2, RAF1, GNB1, CALM1, CXCR4, PRKCA, RIPK1, B2M, ITPR1, IFNA21, IRAK1, TLR2, PLCG1, CFL1, CD3G, BCL2, AP1M2 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P0DP23 | CALM1 | Calmodulin-1 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.761 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P0DP23 | CALM1 | Calmodulin-1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.805 | P0DP25 | CALM3 | Calmodulin-3 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P0DP24 | CALM2 | Calmodulin-2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P0DP23 | CALM1 | Calmodulin-1 | P0DP23 | CALM1 | Calmodulin-1 | 1 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | P0DP23 | CALM1 | Calmodulin-1 | -0.815 | P51684 | CCR6 | C-C chemokine receptor type 6 | P0DP23 | CALM1 | Calmodulin-1 | -0.734 | P0DP25 | CALM3 | Calmodulin-3 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P0DP24 | CALM2 | Calmodulin-2 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P0DP24 | CALM2 | Calmodulin-2 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | 0.759 | P0DP23 | CALM1 | Calmodulin-1 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | P17252 | PRKCA | Protein kinase C alpha type | 0.887 | P51684 | CCR6 | C-C chemokine receptor type 6 | P17252 | PRKCA | Protein kinase C alpha type | 0.738 | P0DP25 | CALM3 | Calmodulin-3 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P0DP24 | CALM2 | Calmodulin-2 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | -0.819 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | -0.868 | P0DP24 | CALM2 | Calmodulin-2 | P61769 | B2M | Beta-2-microglobulin | 0.787 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.793 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.81 | P0DP23 | CALM1 | Calmodulin-1 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | P01568 | IFNA21 | Interferon alpha-21 | 0.876 | P0DP25 | CALM3 | Calmodulin-3 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP24 | CALM2 | Calmodulin-2 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP23 | CALM1 | Calmodulin-1 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.703 | P51684 | CCR6 | C-C chemokine receptor type 6 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | 0.722 | P0DP25 | CALM3 | Calmodulin-3 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.703 | P0DP24 | CALM2 | Calmodulin-2 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.703 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | O60603 | TLR2 | Toll-like receptor 2 | -0.788 | P51684 | CCR6 | C-C chemokine receptor type 6 | O60603 | TLR2 | Toll-like receptor 2 | -0.767 | P0DP23 | CALM1 | Calmodulin-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP25 | CALM3 | Calmodulin-3 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP24 | CALM2 | Calmodulin-2 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP23 | CALM1 | Calmodulin-1 | P23528 | CFL1 | Cofilin-1 | -0.832 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | P23528 | CFL1 | Cofilin-1 | 0.8 | P0DP25 | CALM3 | Calmodulin-3 | P23528 | CFL1 | Cofilin-1 | -0.832 | P0DP24 | CALM2 | Calmodulin-2 | P23528 | CFL1 | Cofilin-1 | -0.832 | P51684 | CCR6 | C-C chemokine receptor type 6 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.753 | P0DP23 | CALM1 | Calmodulin-1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.919 | P51684 | CCR6 | C-C chemokine receptor type 6 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.84 | P0DP25 | CALM3 | Calmodulin-3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP24 | CALM2 | Calmodulin-2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP23 | CALM1 | Calmodulin-1 | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | 0.742 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | -0.838 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | -0.86 | P0DP25 | CALM3 | Calmodulin-3 | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | 0.742 | P0DP24 | CALM2 | Calmodulin-2 | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | 0.742 |
| Promethazine | hsa05171 | Coronavirus disease - COVID-19 | 5.35E-08 | 18 | P01584, P23396, P62753, P25398, P62249, P42677, P40429, P36578, Q02878, P62917, P32969, P27635, Q07020, P46776, P62910, P18077, P05386, P62829 | IL1B, RPS3, RPS6, RPS12, RPS16, RPS27, RPL13A, RPL4, RPL6, RPL8, RPL9, RPL10, RPL18, RPL27A, RPL32, RPL35A, RPLP1, RPL23 | More | | Promethazine | hsa05200 | Pathways in cancer | 4.30E-09 | 28 | P23458, P08238, P42224, P19174, Q15311, P17252, P43246, Q13485, P14923, P10415, Q13489, P49767, P31751, Q08828, P51828, P62873, P61073, P78417, O75293, Q15788, P0DP23, Q13557, O43521, P01568, P14784, P16871, P00734, P01042 | JAK1, HSP90AB1, STAT1, PLCG1, RALBP1, PRKCA, MSH2, SMAD4, JUP, BCL2, BIRC3, VEGFC, AKT2, ADCY1, ADCY7, GNB1, CXCR4, GSTO1, GADD45B, NCOA1, CALM1, CAMK2D, BCL2L11, IFNA21, IL2RB, IL7R, F2, KNG1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P0DP23 | CALM1 | Calmodulin-1 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.822 | P0DP24 | CALM2 | Calmodulin-2 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.738 | P0DP23 | CALM1 | Calmodulin-1 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P0DP25 | CALM3 | Calmodulin-3 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P0DP24 | CALM2 | Calmodulin-2 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P0DP23 | CALM1 | Calmodulin-1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P0DP25 | CALM3 | Calmodulin-3 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P0DP24 | CALM2 | Calmodulin-2 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P0DP23 | CALM1 | Calmodulin-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP25 | CALM3 | Calmodulin-3 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP24 | CALM2 | Calmodulin-2 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP23 | CALM1 | Calmodulin-1 | Q15311 | RALBP1 | RalA-binding protein 1 | 0.858 | P0DP23 | CALM1 | Calmodulin-1 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P0DP25 | CALM3 | Calmodulin-3 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P0DP24 | CALM2 | Calmodulin-2 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P0DP23 | CALM1 | Calmodulin-1 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.944 | P0DP25 | CALM3 | Calmodulin-3 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.944 | P0DP24 | CALM2 | Calmodulin-2 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.944 | P0DP23 | CALM1 | Calmodulin-1 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.777 | P0DP25 | CALM3 | Calmodulin-3 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.777 | P0DP24 | CALM2 | Calmodulin-2 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.777 | P0DP23 | CALM1 | Calmodulin-1 | P14923 | JUP | Junction plakoglobin | -0.852 | P0DP25 | CALM3 | Calmodulin-3 | P14923 | JUP | Junction plakoglobin | -0.852 | P0DP24 | CALM2 | Calmodulin-2 | P14923 | JUP | Junction plakoglobin | -0.852 | P0DP23 | CALM1 | Calmodulin-1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP25 | CALM3 | Calmodulin-3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP24 | CALM2 | Calmodulin-2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP23 | CALM1 | Calmodulin-1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP25 | CALM3 | Calmodulin-3 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP24 | CALM2 | Calmodulin-2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP23 | CALM1 | Calmodulin-1 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.84 | P0DP25 | CALM3 | Calmodulin-3 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.84 | P0DP24 | CALM2 | Calmodulin-2 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.84 | P0DP23 | CALM1 | Calmodulin-1 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.761 | P0DP23 | CALM1 | Calmodulin-1 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.725 | P0DP24 | CALM2 | Calmodulin-2 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.711 | P0DP23 | CALM1 | Calmodulin-1 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.719 | P0DP23 | CALM1 | Calmodulin-1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P0DP25 | CALM3 | Calmodulin-3 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P0DP24 | CALM2 | Calmodulin-2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P0DP24 | CALM2 | Calmodulin-2 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | 0.759 | P0DP23 | CALM1 | Calmodulin-1 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.804 | P0DP25 | CALM3 | Calmodulin-3 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.804 | P0DP24 | CALM2 | Calmodulin-2 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.804 | P0DP23 | CALM1 | Calmodulin-1 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.853 | P0DP25 | CALM3 | Calmodulin-3 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.853 | P0DP24 | CALM2 | Calmodulin-2 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.853 | P0DP24 | CALM2 | Calmodulin-2 | Q15788 | NCOA1 | Nuclear receptor coactivator 1 | 0.731 | P0DP23 | CALM1 | Calmodulin-1 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P0DP25 | CALM3 | Calmodulin-3 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P0DP24 | CALM2 | Calmodulin-2 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P0DP24 | CALM2 | Calmodulin-2 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.786 | P0DP24 | CALM2 | Calmodulin-2 | O43521 | BCL2L11 | Bcl-2-like protein 11 | 0.75 | P0DP23 | CALM1 | Calmodulin-1 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP25 | CALM3 | Calmodulin-3 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP24 | CALM2 | Calmodulin-2 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP23 | CALM1 | Calmodulin-1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.801 | P0DP25 | CALM3 | Calmodulin-3 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.801 | P0DP24 | CALM2 | Calmodulin-2 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.801 | P0DP23 | CALM1 | Calmodulin-1 | P16871 | IL7R | Interleukin-7 receptor subunit alpha | 0.718 | P0DP23 | CALM1 | Calmodulin-1 | P00734 | F2 | Prothrombin | -0.738 | P0DP23 | CALM1 | Calmodulin-1 | P01042 | KNG1 | Kininogen-1 | -0.71 | P0DP25 | CALM3 | Calmodulin-3 | P01042 | KNG1 | Kininogen-1 | -0.71 | P0DP24 | CALM2 | Calmodulin-2 | P01042 | KNG1 | Kininogen-1 | -0.71 |
| Promethazine | hsa05202 | Transcriptional misregulation in cancer | 1.62E-03 | 15 | Q15532, P41732, P14780, P27930, P14923, Q16548, P11215, Q13077, O15550, P35226, P05164, P08246, Q13547, P12980, P24522 | SS18, TSPAN7, MMP9, IL1R2, JUP, BCL2A1, ITGAM, TRAF1, UTX, BMI1, MPO, ELA2, HDAC1, LYL1, GADD45A | More | | Promethazine | hsa05203 | Viral carcinogenesis | 1.22E-03 | 6 | Q13547, Q15283, P58876, P62807, Q16778, O60814 | HDAC1, RASA2, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12 | More | | Promethazine | hsa05204 | Chemical carcinogenesis | 4.02E-05 | 5 | P00325, P09211, P78417, P11712, P33260 | ADH1B, GSTP1, GSTO1, CYP2C9, CYP2C18 | More | | Promethazine | hsa05205 | Proteoglycans in cancer | 1.38E-03 | 10 | Q12955, P04049, Q14247, P14780, P17252, P01375, P23588, Q13635, P22694, P08962 | ANK3, RAF1, CTTN, MMP9, PRKCA, TNF, EIF4B, PTCH1, PRKACB, CD63 | More | | Promethazine | hsa05206 | MicroRNAs in cancer | 4.38E-03 | 3 | P15311, P63279, P04049 | VIL2, UBE2I, RAF1 | More | | Promethazine | hsa05210 | Colorectal cancer | 1.66E-02 | 1 | P04049 | RAF1 | More | | Promethazine | hsa05211 | Renal cell carcinoma | 1.16E-02 | 1 | P04049 | RAF1 | More | | Promethazine | hsa05212 | Pancreatic cancer | 2.36E-04 | 8 | P31751, P04049, Q15311, P23458, P42224, P37173, Q13485, O75293 | AKT2, RAF1, RALBP1, JAK1, STAT1, TGFBR2, SMAD4, GADD45B | More | | Promethazine | hsa05213 | Endometrial cancer | 7.11E-03 | 4 | Q9UJU2, P04049, P04637, P24522 | LEF1, RAF1, TP53, GADD45A | More | | Promethazine | hsa05214 | Glioma | 1.69E-08 | 10 | P0DP23, Q16566, Q13557, P17252, P04049, P31751, P04637, P19174, P24522, O75293 | CALM1, CAMK4, CAMK2D, PRKCA, RAF1, AKT2, TP53, PLCG1, GADD45A, GADD45B | More | | Promethazine | hsa05215 | Prostate cancer | 1.33E-02 | 1 | P04049 | RAF1 | More | | Promethazine | hsa05216 | Thyroid cancer | 5.35E-04 | 3 | Q9UJU2, P04637, P24522 | LEF1, TP53, GADD45A | More | | Promethazine | hsa05217 | Basal cell carcinoma | 4.92E-04 | 4 | Q13635, Q9UJU2, P04637, P24522 | PTCH1, LEF1, TP53, GADD45A | More | | Promethazine | hsa05218 | Melanoma | 6.63E-03 | 1 | P04049 | RAF1 | More | | Promethazine | hsa05219 | Bladder cancer | 4.98E-03 | 1 | P04049 | RAF1 | More | | Promethazine | hsa05220 | Chronic myeloid leukemia | 9.95E-03 | 1 | P04049 | RAF1 | More | | Promethazine | hsa05221 | Acute myeloid leukemia | 8.29E-03 | 1 | P04049 | RAF1 | More | | Promethazine | hsa05223 | Non-small cell lung cancer | 6.63E-03 | 1 | P04049 | RAF1 | More | | Promethazine | hsa05224 | Breast cancer | 8.57E-03 | 4 | P04049, P46531, Q9UM47, O15169 | RAF1, NOTCH1, NOTCH3, AXIN1 | More | | Promethazine | hsa05225 | Hepatocellular carcinoma | 2.85E-03 | 3 | P04049, P60709, P63261 | RAF1, ACTB, ACTG1 | More | | Promethazine | hsa05226 | Gastric cancer | 1.69E-03 | 6 | P04049, Q9UJU2, P04637, P24522, P14923, P10415 | RAF1, LEF1, TP53, GADD45A, JUP, BCL2 | More | | Promethazine | hsa05230 | Central carbon metabolism in cancer | 9.95E-03 | 1 | P04049 | RAF1 | More | | Promethazine | hsa05231 | Choline metabolism in cancer | 1.33E-02 | 1 | P04049 | RAF1 | More | | Promethazine | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 3.92E-03 | 5 | P07766, P20963, P06239, P04049, Q04759 | CD3E, CD247, LCK, RAF1, PRKCQ | More | | Promethazine | hsa05310 | Asthma | 7.24E-04 | 3 | P13765, P29965, P12724 | HLA-DOB, CD40LG, RNASE3 | More | | Promethazine | hsa05320 | Autoimmune thyroid disease | 2.30E-03 | 4 | P13765, P29965, P01568, P10747 | HLA-DOB, CD40LG, IFNA21, CD28 | More | | Promethazine | hsa05321 | Inflammatory bowel disease | 1.13E-04 | 5 | P01375, P13765, Q14765, Q9UL17, Q9HBE5 | TNF, HLA-DOB, STAT4, TBX21, IL21R | More | | Promethazine | hsa05322 | Systemic lupus erythematosus | 8.11E-06 | 12 | P08246, P09871, P10747, P13765, Q6FI13, Q93077, P58876, P62807, Q16778, O60814, P68431, P05455 | ELA2, C1S, CD28, HLA-DOB, H2AC18; H2AC19, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, SSB | More | | Promethazine | hsa05323 | Rheumatoid arthritis | 3.33E-04 | 7 | P09603, P13765, Q13488, P10747, P09341, P19875, O60603 | CSF1, HLA-DOB, TCIRG1, CD28, CXCL1, CXCL2, TLR2 | More | | Promethazine | hsa05330 | Allograft rejection | 1.76E-03 | 4 | P13765, P29965, P48023, P01375 | HLA-DOB, CD40LG, FASLG, TNF | More | | Promethazine | hsa05332 | Graft-versus-host disease | 1.81E-05 | 5 | P13765, P48023, P01375, P26715, Q13241 | HLA-DOB, FASLG, TNF, KLRC1, KLRD1 | More | | Promethazine | hsa05340 | Primary immunodeficiency | 2.14E-03 | 4 | P01732, P11912, P07766, P06239 | CD8A, CD79A, CD3E, LCK | More | | Promethazine | hsa05410 | Hypertrophic cardiomyopathy | 1.02E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Promethazine | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 1.14E-04 | 6 | P54284, P14923, P08514, P60709, P63261, Q9UJU2 | CACNB3, JUP, ITGA2B, ACTB, ACTG1, LEF1 | More | | Promethazine | hsa05414 | Dilated cardiomyopathy | 1.73E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Promethazine | hsa05415 | Diabetic cardiomyopathy | 1.10E-05 | 12 | P17252, P05141, P14598, Q15080, O15239, Q16718, O14521, P13073, Q16539, P49841, Q13557, P37173 | PRKCA, SLC25A5, NCF1, NCF4, NDUFA1, NDUFA5, SDHD, COX4I1, MAPK14, GSK3B, CAMK2D, TGFBR2 | More | | Promethazine | hsa05416 | Viral myocarditis | 1.79E-03 | 4 | P13765, P29965, P60709, P63261 | HLA-DOB, CD40LG, ACTB, ACTG1 | More | | Promethazine | hsa05418 | Fluid shear stress and atherosclerosis | 5.64E-04 | 14 | Q16539, P14598, P78417, P10599, P14780, P01375, P60709, P63261, P10415, P14778, P27930, P0DP23, P08238, Q92974 | MAPK14, NCF1, GSTO1, TXN, MMP9, TNF, ACTB, ACTG1, BCL2, IL1R1, IL1R2, CALM1, HSP90AB1, ARHGEF2 | More | | |